{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:22:01Z","timestamp":1777566121522,"version":"3.51.4"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2012CB114600"],"award-info":[{"award-number":["2012CB114600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Jiangsu University Senior Professional Science Foundation","award":["11JDG120"],"award-info":[{"award-number":["11JDG120"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2012M511206"],"award-info":[{"award-number":["2012M511206"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.fitote.2012.11.003","type":"journal-article","created":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T04:32:15Z","timestamp":1353040335000},"page":"140-157","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Anti-HBV agents derived from botanical origin"],"prefix":"10.1016","volume":"84","author":[{"given":"Li-Peng","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fitote.2012.11.003_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/rmv.554","article-title":"Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future","volume":"18","author":"Ferir","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0010","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jhep.2009.10.033","article-title":"Mechanisms of HBV-related hepatocarcinogenesis","volume":"52","author":"Neuveut","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/589722","article-title":"Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine","volume":"198","author":"Cardell","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.fitote.2012.11.003_bb0020","first-page":"84","article-title":"China's efforts to shed its title of \u201cLeader in liver disease\u201d","volume":"1","author":"Li","year":"2007","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.fitote.2012.11.003_bb0025","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.2165\/00003495-200363200-00007","article-title":"Adefovir dipivoxil: a review of its use in chronic hepatitis B","volume":"63","author":"Dando","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.fitote.2012.11.003_bb0030","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1586\/14789072.2.6.853","article-title":"Entecavir for the treatment of chronic hepatitis B","volume":"2","author":"Shaw","year":"2004","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.fitote.2012.11.003_bb0035","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fitote.2012.11.003_bb0040","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1073\/pnas.87.17.6599","article-title":"Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?","volume":"87","author":"Milich","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fitote.2012.11.003_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2893.2002.00381.x","article-title":"Regulatory elements of hepatitis B virus transcription","volume":"9","author":"Moolla","year":"2002","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.fitote.2012.11.003_bb0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.fitote.2012.11.003_bb0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0166-3542(93)90019-F","article-title":"Effect of an extract from Phyllanthus amarus on hepatitis B surface antigen gene expression in human hepatoma cells","volume":"20","author":"Yeh","year":"1993","journal-title":"Antiviral Res"},{"issue":"76 Suppl.","key":"10.1016\/j.fitote.2012.11.003_bb0060","first-page":"124","article-title":"In vitro inactivation of HBsAg by Eclipta alba Hassk and Phyllanthus niruri Linn","author":"Thyagarajan","year":"1982","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0065","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1365-2362.1996.410595.x","article-title":"Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication","volume":"26","author":"Lee","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.fitote.2012.11.003_bb0070","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1365-2362.1997.2020749.x","article-title":"Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors","volume":"27","author":"Ott","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.fitote.2012.11.003_bb0075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/jcb.20611","article-title":"Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis","volume":"97","author":"Lam","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.fitote.2012.11.003_bb0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/ptr.1167","article-title":"Screening of 25 compounds isolated from Phyllanthus species for anti-human hepatitis B virus in vitro","volume":"17","author":"Huang","year":"2003","journal-title":"Phytother Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.antiviral.2005.06.005","article-title":"A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes","volume":"67","author":"Shin","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0090","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1248\/bpb.31.743","article-title":"Anti-hepatitis B virus activities of Geranium carolinianum L. extracts and identification of the active components","volume":"31","author":"Li","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.fitote.2012.11.003_bb0095","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2005.07.005","article-title":"Effect of artemisinin\/artesunate as inhibitors of hepatitis B virus production in an \u201cin vitro\u201d replicative system","volume":"68","author":"Romero","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0100","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.febslet.2009.12.019","article-title":"Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway","volume":"584","author":"Kim","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.fitote.2012.11.003_bb0105","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1073\/pnas.90.5.1839","article-title":"Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication","volume":"90","author":"Li","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fitote.2012.11.003_bb0110","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.febslet.2010.04.067","article-title":"Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha","volume":"584","author":"Rechtman","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.fitote.2012.11.003_bb0115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm034265a","article-title":"Synthesis and antiviral activity of helioxanthin analogues","volume":"48","author":"Yeo","year":"2005","journal-title":"J Med Chem"},{"issue":"Suppl. 1","key":"10.1016\/j.fitote.2012.11.003_bb0120","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/S1386-6532(05)80026-5","article-title":"New targets and inhibitors of HBV replication to combat drug resistance","volume":"34","author":"Cheng","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/095632020501600305","article-title":"Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative","volume":"16","author":"Li","year":"2005","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.fitote.2012.11.003_bb0130","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1073\/pnas.0609883104","article-title":"Unique antiviral mechanism discovered in anti-hepatitis B virus research with a natural product analogue","volume":"104","author":"Ying","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fitote.2012.11.003_bb0135","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1111\/j.1572-0241.2005.00262.x","article-title":"Milk thistle for alcoholic and\/or hepatitis B or C liver diseases\u2014a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials","volume":"100","author":"Rambaldi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0140","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/hep.23587","article-title":"Multiple effects of silymarin on the hepatitis C virus lifecycle","volume":"51","author":"Wagoner","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.fitote.2012.11.003_bb0145","doi-asserted-by":"crossref","first-page":"e16464","DOI":"10.1371\/journal.pone.0016464","article-title":"Differential in vitro effects of intravenous versus oral formulations of silibinin on the HCV life cycle and inflammation","volume":"6","author":"Wagoner","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.fitote.2012.11.003_bb0150","doi-asserted-by":"crossref","first-page":"e41832","DOI":"10.1371\/journal.pone.0041832","article-title":"Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation","volume":"7","author":"McClure","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.fitote.2012.11.003_bb0155","unstructured":"Wu XD, Li XP, Lu L, Feng YB, Li F, Wu XM, et al. Application of dimethyldehydrosilybin in preparation of medicines for treating viral hepatitis B. Patent. 2012\u201303\u201328.CN 101912385 B."},{"key":"10.1016\/j.fitote.2012.11.003_bb0160","unstructured":"Peng F, Wang CF, Yang YS, Feng YB, Yue JM, Wu XM, et al. Application of E ring-demethylsilybin in preparation of medicines for treating viral hepatitis B. Patent. 2012\u201310\u201310. CN 101912383 B."},{"key":"10.1016\/j.fitote.2012.11.003_bb0165","unstructured":"Peng F, Chen HY, Yang YE, Hu MH, Yu RM, Wu XM, et al. Application of substituted silybin ester in preparation of medicines for treating viral hepatitis B. Patent. 2012-05-23. CN 101829083 B."},{"key":"10.1016\/j.fitote.2012.11.003_bb0170","unstructured":"Guo XG, Xiao YC, Jiao CX, Li HB, Yu RM, Wu XM, et al. Application of ethoxylsilybin in preparation of medicines for treating viral hepatitis B. Patent. 2012-02-01. CN 101829089 B."},{"key":"10.1016\/j.fitote.2012.11.003_bb0175","unstructured":"Zhou CX, Feng JH, Shen YY, Gong JX, Fan YJ, Wu XM, et al. Application of A-ring substituted silybin in preparation of medicines for treating viral hepatitis B. Patent. 2012-05-23. CN 101829101 B."},{"key":"10.1016\/j.fitote.2012.11.003_bb0180","unstructured":"Liu GM, Wang LW, Hu YF, Wang F, Fu HB, Wu XM, et al. Application of (phenylcarbamyl-methyl)dehydrosilybin in preparation of medicines for treating viral hepatitis B. Patent. 2012-05-23. CN 101829086 B."},{"key":"10.1016\/j.fitote.2012.11.003_bb0185","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1248\/bpb.29.2131","article-title":"In vitro antiviral activity of 1,2,3,4,6-penta-O-galloyl-beta-d-glucose against hepatitis B virus","volume":"29","author":"Lee","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.fitote.2012.11.003_bb0190","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ptr.832","article-title":"Antiviral activities of extracts isolated from Terminalis chebula Retz., Sanguisorba officinalis L., Rubus coreanus Miq. and Rheum palmatum L. against hepatitis B virus","volume":"15","author":"Kim","year":"2001","journal-title":"Phytother Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0195","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2006.12.005","article-title":"Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo","volume":"74","author":"Zhou","year":"2007","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0200","first-page":"179","article-title":"Anti-hepatitis B virus of seven compounds isolated from Piper Kadsura (Choisy) Ohwi","volume":"12","author":"Huang","year":"2001","journal-title":"J Chin Med"},{"key":"10.1016\/j.fitote.2012.11.003_bb0205","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1055\/s-2005-871271","article-title":"Antihepatitis activity (anti-HBsAg and anti-HBeAg) of C19 homolignans and six novel C18 dibenzocyclooctadiene lignans from Kadsura japonica","volume":"71","author":"Kuo","year":"2005","journal-title":"Planta Med"},{"key":"10.1016\/j.fitote.2012.11.003_bb0210","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/147323000903700308","article-title":"Clinical and experimental effectiveness of Astragali compound in the treatment of chronic viral hepatitis B","volume":"37","author":"Tang","year":"2009","journal-title":"J Int Med Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0215","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1248\/bpb.32.132","article-title":"Anti-hepatitis B virus activities of astragaloside IV isolated from radix Astragali","volume":"32","author":"Wang","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.fitote.2012.11.003_bb0220","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1055\/s-2006-947178","article-title":"A new triterpene and anti-hepatitis B virus active compounds from Alisma orientalis","volume":"72","author":"Jiang","year":"2006","journal-title":"Planta Med"},{"key":"10.1016\/j.fitote.2012.11.003_bb0225","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1016\/j.bmcl.2008.07.012","article-title":"Anti-HBV agents. Part 1: Synthesis of alisol A derivatives: a new class of hepatitis B virus inhibitors","volume":"18","author":"Zhang","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.fitote.2012.11.003_bb0230","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.bmcl.2009.02.122","article-title":"Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives","volume":"19","author":"Zhang","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.fitote.2012.11.003_bb0235","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1016\/j.bmcl.2009.10.006","article-title":"Anti-HBV agents. Part 3: preliminary structure-activity relationships of tetra-acylalisol A derivatives as potent hepatitis B virus inhibitors","volume":"19","author":"Zhang","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.fitote.2012.11.003_bb0240","doi-asserted-by":"crossref","first-page":"247597","DOI":"10.1155\/2012\/247597","article-title":"Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug","volume":"2012","author":"Crespo-Ortiz","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbrc.2006.07.014","article-title":"Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin","volume":"348","author":"Paesuyse","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.fitote.2012.11.003_bb0250","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4269\/ajtmh.1999.60.547","article-title":"Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives","volume":"60","author":"Price","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.fitote.2012.11.003_bb0255","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0035-9203(98)91081-1","article-title":"Artemisinin derivatives in the treatment of falciparum malaria in pregnancy","volume":"92","author":"McGready","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.fitote.2012.11.003_bb0260","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.fitote.2012.11.003_bb0265","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jep.2009.06.030","article-title":"Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum","volume":"125","author":"Zhao","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0166-3542(94)00083-K","article-title":"Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells","volume":"27","author":"Chen","year":"1995","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6346(00)00123-6","article-title":"Treatment of subacute hepatitis with Lamivudine and intravenous Glycyrrhizin: a pilot study","volume":"20","author":"Tandon","year":"2001","journal-title":"Hepatol Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0280","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0168-8278(94)80108-8","article-title":"Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study","volume":"21","author":"Takahara","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0285","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0166-3542(96)00942-4","article-title":"Therapeutic basis of glycyrrhizin on chronic hepatitis B","volume":"30","author":"Sato","year":"1996","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0290","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/s-2003-42797","article-title":"Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species","volume":"69","author":"Chiang","year":"2003","journal-title":"Planta Med"},{"key":"10.1016\/j.fitote.2012.11.003_bb0295","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/095632020501600407","article-title":"In vitro antiviral activity of three enantiomeric sesquiterpene lactones from Senecio species against hepatitis B virus","volume":"16","author":"Li","year":"2005","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.fitote.2012.11.003_bb0300","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1021\/ol051155k","article-title":"Kadsuphilactones A and B, two new triterpene dilactones from kadsuraphilippinensis","volume":"7","author":"Shen","year":"2005","journal-title":"Org Lett"},{"key":"10.1016\/j.fitote.2012.11.003_bb0305","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.antiviral.2008.03.001","article-title":"In vitro and in vivo anti-hepatitis B virus activities of a plant extract from Geranium carolinianum L","volume":"79","author":"Li","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0310","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1745-7254.2007.00510.x","article-title":"In vivo and in vitro antiviral activity of hyperoside extracted from Abelmoschus manihot (L) medik","volume":"28","author":"Wu","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.fitote.2012.11.003_bb0315","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1055\/s-2000-9775","article-title":"Anti-hepatitis B virus effects of wogonin isolated from Scutellaria baicalensis","volume":"66","author":"Huang","year":"2000","journal-title":"Planta Med"},{"key":"10.1016\/j.fitote.2012.11.003_bb0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2007.01.002","article-title":"Anti-hepatitis B virus activity of wogonin in vitro and in vivo","volume":"74","author":"Guo","year":"2007","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0325","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0166-3542(98)00033-3","article-title":"Robustaflavone, a potential non-nucleoside anti-hepatitis B agent","volume":"39","author":"Zembower","year":"1998","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0330","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/np0401819","article-title":"Homoflavonoids from Ophioglossum petiolatum","volume":"68","author":"Lin","year":"2005","journal-title":"J Nat Prod"},{"key":"10.1016\/j.fitote.2012.11.003_bb0335","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1177\/147323000903700515","article-title":"Inhibition of the replication of hepatitis B virus in vitro by oxymatrine","volume":"37","author":"Lin","year":"2009","journal-title":"J Int Med Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0340","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3748\/wjg.v7.i1.49","article-title":"Inhibition of hepatitis B virus by oxymatrine in vivo","volume":"7","author":"Chen","year":"2001","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0345","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3748\/wjg.v9.i11.2480","article-title":"Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial","volume":"9","author":"Lu","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0350","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.antiviral.2011.01.005","article-title":"Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance","volume":"89","author":"Wang","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0355","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1128\/AAC.01764-09","article-title":"Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus","volume":"54","author":"Wang","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.fitote.2012.11.003_bb0360","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/jm101325h","article-title":"Design and synthesis of oxymatrine analogues overcoming drug resistance in hepatitis b virus through targeting host heat stress cognate 70","volume":"54","author":"Gao","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.fitote.2012.11.003_bb0365","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bmcl.2005.11.073","article-title":"(+)-12alpha-Hydroxysophocarpine, a new quinolizidine alkaloid and related anti-HBV alkaloids from Sophora flavescens","volume":"16","author":"Ding","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.fitote.2012.11.003_bb0370","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1073\/pnas.91.6.2235","article-title":"Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin","volume":"91","author":"Block","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fitote.2012.11.003_bb0375","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1073\/pnas.94.5.1822","article-title":"Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion","volume":"94","author":"Mehta","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fitote.2012.11.003_bb0380","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.antiviral.2007.04.004","article-title":"Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity","volume":"76","author":"Lazar","year":"2007","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0385","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1053\/jhep.2001.25103","article-title":"Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications","volume":"33","author":"Mehta","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.fitote.2012.11.003_bb0390","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1128\/AAC.46.12.4004-4008.2002","article-title":"Structure-activity relationship of a new class of anti-hepatitis B virus agents","volume":"46","author":"Mehta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.fitote.2012.11.003_bb0395","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/095632020701800105","article-title":"Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus","volume":"18","author":"Gu","year":"2007","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.fitote.2012.11.003_bb0400","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1128\/AAC.48.6.2085-2090.2004","article-title":"alpha-Galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses","volume":"48","author":"Mehta","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.fitote.2012.11.003_bb0405","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2012.02.030","article-title":"In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates","volume":"683","author":"Zhou","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0410","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1055\/s-2007-981549","article-title":"Two new quaternary alkaloids and anti-hepatitis B virus active constituents from Corydalis saxicola","volume":"73","author":"Wu","year":"2007","journal-title":"Planta Med"},{"key":"10.1016\/j.fitote.2012.11.003_bb0415","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000107690","article-title":"Identification of natural compounds with anti-hepatitis B virus activity from Rheum palmatum L. ethanol extract","volume":"53","author":"Li","year":"2007","journal-title":"Chemotherapy"},{"key":"10.1016\/j.fitote.2012.11.003_bb0420","first-page":"BR302","article-title":"Inhibition of the replication of hepatitis B virus in vitro by emodin","volume":"12","author":"Shuangsuo","year":"2006","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.fitote.2012.11.003_bb0425","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1021\/np960200h","article-title":"Inhibition of hepatitis B surface antigen secretion on human hepatoma cells. Components from Rubia cordifolia","volume":"59","author":"Ho","year":"1996","journal-title":"J Nat Prod"},{"key":"10.1016\/j.fitote.2012.11.003_bb0430","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1016\/j.bmc.2008.12.007","article-title":"Anti-HBV and cytotoxic activities of pyranocoumarin derivatives","volume":"17","author":"Su","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.fitote.2012.11.003_bb0435","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/j.bmc.2009.03.003","article-title":"Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives","volume":"17","author":"Xu","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.fitote.2012.11.003_bb0440","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1016\/j.bmc.2011.08.001","article-title":"Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents","volume":"19","author":"Qiu","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.fitote.2012.11.003_bb0445","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.3748\/wjg.v12.i35.5721","article-title":"Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells","volume":"12","author":"Huang","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0450","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2893.2009.01072.x","article-title":"Involvement of GRP78 in inhibition of HBV secretion by Boehmeria nivea extract in human HepG2 2.2.15 cells","volume":"16","author":"Huang","year":"2009","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.fitote.2012.11.003_bb0455","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jep.2008.03.024","article-title":"In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica","volume":"11","author":"Han","year":"2008","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0460","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1745-7254.2005.00055.x","article-title":"Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection","volume":"26","author":"Wang","year":"2005","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.fitote.2012.11.003_bb0465","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.antiviral.2004.12.006","article-title":"Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line","volume":"66","author":"Chang","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0470","doi-asserted-by":"crossref","first-page":"939205","DOI":"10.1093\/ecam\/neq011","article-title":"Ethanol extract from Ampelopsis sinica root exerts anti-hepatitis B virus activity via inhibition of p53 pathway in vitro","volume":"2011","author":"Pang","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.fitote.2012.11.003_bb0475","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11596-010-0118-0","article-title":"In vitro anti-hepatitis B virus effect of Hypericum perforatum L","volume":"30","author":"Pang","year":"2010","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"10.1016\/j.fitote.2012.11.003_bb0480","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ptr.1689","article-title":"Inhibition of hepatitis B virus by an aqueous extract of Agrimonia eupatoria L","volume":"19","author":"Kwon","year":"2005","journal-title":"Phytother Res"},{"issue":"Suppl. 1","key":"10.1016\/j.fitote.2012.11.003_bb0485","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2010.06545.x","article-title":"Treatment of chronic hepatitis B: evolution over two decades","volume":"26","author":"Yuen","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0490","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.antiviral.2008.07.010","article-title":"Understanding the molecular basis of HBV drug resistance by molecular modeling","volume":"80","author":"Sharon","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0495","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1586\/14787210.4.4.549","article-title":"Clevudine: a potent inhibitor of hepatitis B virus in vitro and in vivo","volume":"4","author":"Korba","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.fitote.2012.11.003_bb0500","first-page":"65","article-title":"The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues","volume":"9","author":"Ladner","year":"1998","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.fitote.2012.11.003_bb0505","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1081\/NCN-120022723","article-title":"Monoval-LdC: efficient prodrug of 2\u2032-deoxy-beta-L-cytidine (L-dC), a potent and selective anti-HBV agent","volume":"22","author":"Benzaria","year":"2003","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.fitote.2012.11.003_bb0510","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/135965350601100806","article-title":"A randomized placebo-controlled, dose-finding study of oral LB80380 in HBeAg-positive patients with chronic hepatitis B","volume":"11","author":"Yuen","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.fitote.2012.11.003_bb0515","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1517\/13543784.17.10.1581","article-title":"LB80380: a promising new drug for the treatment of chronic hepatitis B","volume":"17","author":"Fung","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.fitote.2012.11.003_bb0520","first-page":"109","article-title":"HepDirect prodrugs for targeting nucleotide-based antiviral drugs to the liver","volume":"7","author":"Erion","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.fitote.2012.11.003_bb0525","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","article-title":"Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein","volume":"79","author":"Gripon","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0530","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein","volume":"26","author":"Petersen","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0535","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1038\/sj.onc.1204805","article-title":"Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity","volume":"20","author":"Butz","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.fitote.2012.11.003_bb0540","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.virusres.2010.03.005","article-title":"Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein","volume":"150","author":"Han","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0545","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/AAC.42.12.3179","article-title":"Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (\u2212)beta-L-2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine","volume":"42","author":"King","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.fitote.2012.11.003_bb0550","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2007.06.014","article-title":"The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging","volume":"76","author":"Feld","year":"2007","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0555","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.1077215","article-title":"Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids","volume":"299","author":"Deres","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.fitote.2012.11.003_bb0560","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.0409732102","article-title":"A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly","volume":"102","author":"Stray","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.fitote.2012.11.003_bb0565","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1179\/joc.2008.20.4.458","article-title":"Inhibition of hepatitis B virus replication by Bay 41\u20134109 and its association with nucleocapsid disassembly","volume":"20","author":"Wu","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.fitote.2012.11.003_bb0570","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/jhep.2003.50146","article-title":"Inhibition of hepatitis B virus expression and replication by RNA interference","volume":"37","author":"Shlomai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.fitote.2012.11.003_bb0575","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nbt824","article-title":"Inhibition of hepatitis B virus in mice by RNA interference","volume":"21","author":"McCaffrey","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0580","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1096\/fj.11-187781","article-title":"A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication","volume":"25","author":"Chen","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.fitote.2012.11.003_bb0585","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/jmv.21970","article-title":"Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication","volume":"83","author":"Tatematsu","year":"2011","journal-title":"J Med Virol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0590","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.antiviral.2011.08.012","article-title":"The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication","volume":"92","author":"Billioud","year":"2011","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0595","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.antiviral.2010.02.325","article-title":"Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro","volume":"86","author":"Bader","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0600","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.bbrc.2010.04.128","article-title":"Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone","volume":"396","author":"Wakui","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.fitote.2012.11.003_bb0605","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.fct.2009.12.011","article-title":"Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage","volume":"48","author":"Shaker","year":"2010","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0610","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/0006-2952(92)90168-I","article-title":"Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phospholipid complex IdB 1016","volume":"43","author":"Carini","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.fitote.2012.11.003_bb0615","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1158\/0008-5472.CAN-07-2450","article-title":"Chemopreventive effect of silymarin on liver pathology in HBV X protein transgenic mice","volume":"68","author":"Wu","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.fitote.2012.11.003_bb0620","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/092986707779941159","article-title":"Silybin and silymarin\u2014new and emerging applications in medicine","volume":"14","author":"Gazak","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.fitote.2012.11.003_bb0625","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/pmic.200800621","article-title":"Proteome responses to stable hepatitis B virus transfection and following interferon alpha treatment in human liver cell line HepG2","volume":"9","author":"Wang","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.fitote.2012.11.003_bb0630","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1745-7254.2007.00590.x","article-title":"Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment","volume":"28","author":"Xie","year":"2007","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.fitote.2012.11.003_bb0635","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/hep.23669","article-title":"Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin","volume":"52","author":"Galli","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.fitote.2012.11.003_bb0640","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.2174\/138161210791164072","article-title":"Identification of bioactive natural products by pharmacophore-based virtual screening","volume":"16","author":"Schuster","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.fitote.2012.11.003_bb0645","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/cmdc.200900070","article-title":"Pharmacophore-based discovery of small-molecule inhibitors of protein\u2013protein interactions between HIV-1 integrase and cellular cofactor LEDGF\/p75","volume":"4","author":"De Luca","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.fitote.2012.11.003_bb0650","doi-asserted-by":"crossref","first-page":"e36363","DOI":"10.1371\/journal.pone.0036363","article-title":"A novel inhibitor of human La protein with anti-HBV activity discovered by structure-based virtual screening and in vitro evaluation","volume":"7","author":"Tang","year":"2012","journal-title":"PLoS One"}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X12002961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X12002961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T16:35:16Z","timestamp":1687797316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X12002961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":130,"alternative-id":["S0367326X12002961"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2012.11.003","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}